Evidence map›Paper›PMID 26288016›Full record

ArticlePloS one2015

Microglia Induce Neurotoxic IL-17+ γδ T Cells Dependent on TLR2, TLR4, and TLR9 Activation.

Katja Derkow, Christina Krüger, Paul Dembny, Seija Lehnardt

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Th17 Cells and IL-17A in Ischemic Stroke.Molecular neurobiology · 2024
    Review
  11. Article
  12. Review
  13. Article
  14. Role of microglia in HIV-1 infection.AIDS research and therapy · 2023
    Review
  15. Tissue-resident immune cells in the pathogenesis of multiple sclerosis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2023
    Review
  16. Inflammatory Responses After Ischemic Stroke.Seminars in immunopathology · 2022
    Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Katja DerkowDepartment of Neurology, Charité - Universitaetsmedizin Berlin, Berlin, Germany.
Christina KrügerDepartment of Neurology, Charité - Universitaetsmedizin Berlin, Berlin, Germany.
Paul DembnyDepartment of Neurology, Charité - Universitaetsmedizin Berlin, Berlin, Germany.
Seija LehnardtDepartment of Neurology, Charité - Universitaetsmedizin Berlin, Berlin, Germany; Cluster of Excellence NeuroCure, Charité - Universitaetsmedizin Berlin, Berlin, Germany; Institute of Cell Biology and Neurobiology, Center for Anatomy, Charité - Universitaetsmedizin Berlin, Berlin, Germany.
Charité - Universitätsmedizin Berlin · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInterleukin-17 (IL-17) acts as a key regulator in central nervous system (CNS) inflammation. γδ T cells are an important innate source of IL-17. Both IL-17+ γδ T cells and microglia, the major resident immune cells of the brain, are involved in various CNS disorders such as multiple sclerosis and stroke. Also, activation of Toll-like receptor (TLR) signaling pathways contributes to CNS damage. However, the mechanisms underlying the regulation and interaction of these cellular and molecular components remain unclear.

objectiveIn this study, we investigated the crosstalk between γδ T cells and microglia activated by TLRs in the context of neuronal damage. To this end, co-cultures of IL-17+ γδ T cells, neurons, and microglia were analyzed by immunocytochemistry, flow cytometry, ELISA and multiplex immunoassays.

resultsWe report here that IL-17+ γδ T cells but not naïve γδ T cells induce a dose- and time-dependent decrease of neuronal viability in vitro. While direct stimulation of γδ T cells with various TLR ligands did not result in up-regulation of CD69, CD25, or in IL-17 secretion, supernatants of microglia stimulated by ligands specific for TLR2, TLR4, TLR7, or TLR9 induced activation of γδ T cells through IL-1β and IL-23, as indicated by up-regulation of CD69 and CD25 and by secretion of vast amounts of IL-17. This effect was dependent on the TLR adaptor myeloid differentiation primary response gene 88 (MyD88) expressed by both γδ T cells and microglia, but did not require the expression of TLRs by γδ T cells. Similarly to cytokine-primed IL-17+ γδ T cells, IL-17+ γδ T cells induced by supernatants derived from TLR-activated microglia also caused neurotoxicity in vitro. While these neurotoxic effects required stimulation of TLR2, TLR4, or TLR9 in microglia, neuronal injury mediated by bone marrow-derived macrophages did not require TLR signaling. Neurotoxicity mediated by IL-17+ γδ T cells required a direct cell-cell contact between T cells and neurons.

conclusionTaken together, these results point to a crucial role for microglia activated through TLRs in polarization of γδ T cells towards neurotoxic IL-17+ γδ T cells.

Indexed as

AnimalsAntigens, CDAntigens, Differentiation, T-LymphocyteCD69 AntigensCells, CulturedEncephalomyelitis, Autoimmune, ExperimentalEnzyme ActivationInterleukin-17Interleukin-1betaInterleukin-23 Subunit p19Interleukin-2 Receptor alpha SubunitLectins, C-TypeMacrophagesMembrane GlycoproteinsMiceMice, Inbred C57BLAntigens, CDAntigens, Differentiation, T-LymphocyteCD69 AntigensIL1B protein, mouseIl23a protein, mouseInterleukin-17Interleukin-1betaInterleukin-23 Subunit p19Interleukin-2 Receptor alpha SubunitLectins, C-TypeMembrane GlycoproteinsMyd88 protein, mouseMyeloid Differentiation Factor 88Receptors, Antigen, T-Cell, gamma-deltaTlr2 protein, mouseTlr4 protein, mouseTlr7 protein, mouseTlr9 protein, mouseToll-Like Receptor 2Toll-Like Receptor 4Toll-Like Receptor 7Toll-Like Receptor 9

Identifiers

PMID26288016
PMCPMC4545749
OpenAlexW1874066939

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.